
Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2â²-deoxy-2â²-fluoro- 4â²-azido nucleoside derivatives as potent anti-HBV agents
Keywords: 2â²-deoxy-2â²-β-fluoro-4â²-azido-β-d-arabinofuranosyl 1,2,3-triazole nucleoside; Anti-HBV activity; Nucleoside reverse transcriptase inhibitor (NRTI); Lamivudine-resistant HBV mutants; Viral DNA replication; HBV; hepatitis B virus; HCV; hepatitis C v